Citadel Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Citadel Advisors’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41,280	Closed	-$301K	–	15997
2022 Q4	$301K	Sell	41,280 -23,768	-37%	-$168K	﹤0.01%	9315
2022 Q3	$450K	Sell	65,048 -26,447	-29%	-$197K	﹤0.01%	8701
2022 Q2	$640K	Buy	91,495 +48,085	+111%	+$375K	﹤0.01%	8090
2022 Q1	$359K	Sell	43,410 -529	-1%	-$4.77K	﹤0.01%	10174
2021 Q4	$475K	Buy	43,939 +32,318	+278%	+$349K	﹤0.01%	9827
2021 Q3	$141K	Buy	11,621 +491	+4%	+$5.54K	﹤0.01%	12451
2021 Q2	$135K	Buy	+11,130	New	+$138K	﹤0.01%	12619

Other funds holding AMYT

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citadel Advisors's AMYT Position: Q1 2023 in Review

Citadel Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 41,280 shares — an estimated $301K sold.

Citadel Advisors first reported a position in AMYT in Q2 2021 and held it in 7 quarters. The position peaked at $640K in Q2 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

Citadel Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Citadel Advisors sold 41,280 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $301K.
Citadel Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2021 and held it in 7 quarters.
Citadel Advisors's Amryt Pharma plc American Depositary Shares position peaked at $640K in Q2 2022.
79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.